LRIG1 Blocking Peptide (C-term)
€363.00
In stock
SKU
AC-BP19769b
Background:
LRIG1 act as a feedback negative regulator of signaling by receptor tyrosine kinases, through a mechanism that involves enhancement of receptor ubiquitination and accelerated intracellular degradation.
Other Names:
Leucine-rich repeats and immunoglobulin-like domains protein 1, LIG-1, LRIG1, LIG1
Target/Specificity:
The synthetic peptide sequence is selected from aa 816-829 of HUMAN LRIG1
Gene Name: LRIG1 {ECO:0000303|PubMed:15282549}
Gene ID: 26018
Primary Accession: Q96JA1
Other Accession: P70193; NP_056356.2
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
LRIG1 act as a feedback negative regulator of signaling by receptor tyrosine kinases, through a mechanism that involves enhancement of receptor ubiquitination and accelerated intracellular degradation.
Other Names:
Leucine-rich repeats and immunoglobulin-like domains protein 1, LIG-1, LRIG1, LIG1
Target/Specificity:
The synthetic peptide sequence is selected from aa 816-829 of HUMAN LRIG1
Gene Name: LRIG1 {ECO:0000303|PubMed:15282549}
Gene ID: 26018
Primary Accession: Q96JA1
Other Accession: P70193; NP_056356.2
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review